What is Zacks Research's Estimate for Clorox Q1 Earnings?

Key Points

• Zacks Research cut Clorox’s Q1 2027 EPS estimate to $1.02 from $1.28 and maintained a “Strong Sell” rating. The broader consensus forecast for full-year earnings is $5.80 per share.
• Analyst sentiment remains cautious, with Clorox carrying an average “Reduce” rating and a consensus price target of $102.40. Recent targets range from $84 to $102, while the stock recently opened at $105.86.
• Clorox’s latest quarterly results modestly exceeded expectations, but revenue fell 2% year over year and EPS declined from $2.87 to $1.66. The company raised its quarterly dividend to $1.25, producing a 4.7% yield, though its payout ratio exceeds 100%.

The Clorox Company (NYSE:CLX - Free Report) - Analysts at Zacks Research dropped their Q1 2027 earnings estimates for Clorox in a report issued on Monday, August 17th. Zacks Research analyst Team now expects that the company will earn $1.02 per share for the quarter, down from their prior forecast of $1.28. Zacks Research has a "Strong Sell" rating on the stock. The consensus estimate for Clorox's current full-year earnings is $5.80 per share.

A number of other brokerages also recently issued reports on CLX. Deutsche Bank Aktiengesellschaft set a $98.00 price objective on shares of Clorox in a research report on Tuesday, August 4th. JPMorgan Chase & Co. upped their price target on shares of Clorox from $92.00 to $95.00 and gave the stock an "underweight" rating in a research report on Tuesday, August 4th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Clorox in a research note on Friday, July 10th. Barclays reissued an "underweight" rating and issued a $84.00 price target on shares of Clorox in a report on Tuesday, August 4th. Finally, Wells Fargo & Company raised their target price on shares of Clorox from $95.00 to $102.00 and gave the company an "equal weight" rating in a research note on Tuesday, August 4th. Twelve analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Reduce" and a consensus target price of $102.40.

Clorox Price Performance

NYSE CLX opened at $105.86 on Wednesday. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The firm has a market capitalization of $12.80 billion, a P/E ratio of 21.96, a PEG ratio of 3.15 and a beta of 0.54. The company has a 50-day moving average price of $98.44 and a 200-day moving average price of $103.17. Clorox has a 52 week low of $84.70 and a 52 week high of $128.90.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.02. The firm had revenue of $1.95 billion for the quarter, compared to analysts' expectations of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The company's revenue was down 2.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th will be given a $1.25 dividend. This is a positive change from Clorox's previous quarterly dividend of $1.24. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $5.00 annualized dividend and a yield of 4.7%. Clorox's dividend payout ratio is presently 103.73%.

Hedge Funds Weigh In On Clorox

A number of institutional investors have recently modified their holdings of the stock. Haverford Trust Co boosted its stake in Clorox by 2.8% during the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company's stock worth $310,000 after acquiring an additional 84 shares in the last quarter. Field & Main Bank lifted its stake in Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company's stock valued at $313,000 after acquiring an additional 100 shares in the last quarter. Golden State Wealth Management LLC boosted its holdings in Clorox by 28.2% during the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company's stock worth $46,000 after acquiring an additional 100 shares during the last quarter. Kestra Private Wealth Services LLC boosted its holdings in Clorox by 1.8% during the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company's stock worth $617,000 after acquiring an additional 104 shares during the last quarter. Finally, Johnson Financial Group Inc. grew its stake in shares of Clorox by 3.1% in the 3rd quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company's stock worth $451,000 after acquiring an additional 109 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Zacks Research raised its estimates for Clorox’s third-quarter 2027 EPS to $1.62 from $1.57 and fourth-quarter 2027 EPS to $1.82 from $1.71. It also modestly increased estimates for the third and fourth quarters of 2028 and projects FY2029 EPS of $6.89, indicating some longer-term earnings potential. Zacks Research Clorox estimates
• Neutral Sentiment: Clorox’s relatively high dividend yield remains attractive to income-oriented investors, although the company has been cautious with dividend increases. The comparison with Church & Dwight highlights CLX’s stronger current income but slower dividend-growth profile. Two Consumer Staples, Two Dividend Strategies
• Negative Sentiment: Zacks Research retained a “Strong Sell” rating and reduced its FY2027 EPS forecast to $5.82 from $6.00 and FY2028 EPS to $6.23 from $6.36. Estimates were also cut for the second quarter of 2027 and the first and second quarters of 2028, offsetting the increases elsewhere and signaling uneven earnings momentum. Zacks Research earnings estimates
• Negative Sentiment: An analyst cited declining sales for Hidden Valley Ranch as consumers become more cautious about buying salad ingredients amid a cyclospora outbreak. The development raises concerns about near-term demand for one of Clorox’s important brands. Hidden Valley Ranch dressing may be a victim of this summer’s salad scare

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source